#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Retinopathy proliferative Blastic plasmacytoid dendritic cell neoplasia Ewing's sarcoma recurrent Type IIa hyperlipidaemia Intracranial calcification Medulloblastoma Oesophageal achalasia Pulmonary fibrosis Pleomorphic liposarcoma Systemic mastocytosis Enteritis Autoinflammation with infantile enterocolitis Necrotising enterocolitis neonatal Hodgkin's disease recurrent Thromboangiitis obliterans More trials…

    Learn about Rare Diseases

    Gaucher’s disease type III – Basic Information Haemophilia B without inhibitors – Basic Information Pulmonary fibrosis – Life with Disease Mantle cell lymphoma stage III – Life with Disease Idiopathic inflammatory myopathy – Trials in Disease Hairy cell leukaemia – Life with Disease Myxofibrosarcoma – Diagnostics Glycogen storage disease type V – Life with Disease Phenylketonuria – Trials in Disease Rhabdoid tumour – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    VIPOGLANSTAT Ethanol, Anhydrous Nortriptyline Hydrochloride Sodium Fluoride (18F) AGALSIDASE BETA Bhv-7000 Pasireotide Lenalidomide Lutikizumab Aflibercept Fluasterone Nms-03305293 Piperacillin Monohydrate Terbinafine Hydrochloride Murcidencel Cefiderocol POTASSIUM CLAVULANATE Dried Ferrous Sulfate Lurbinectedin Dexamethasone Phosphate More therapies…

    Learn about Your Condition

    Endocrine ophthalmopathy Eye pain Sleep disorder Osteopenia Ovarian cancer metastatic Immunodeficiency Piriformis syndrome Atrophic vulvovaginitis Carcinoid tumour pulmonary Cardiogenic shock Ejection fraction normal Device related infection Procedural haemorrhage Idiopathic pulmonary fibrosis Propionic acidaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • A Study of CRN09682 for Patients with Neuroendocrine Tumors and Other Solid Tumors that Express Somatostatin Receptor Type 2

    Recruiting

    2 1 1
    Investigated Diseases:
    • Neuroendocrine tumour
    • Neoplasm
    France Germany Italy Spain

  • A Study of Tarperprumig Safety and Effectiveness in Adults with Blood Vessel Inflammation Caused by ANCA Antibodies

    Recruiting

    2 1
    Investigated Diseases:
    • Anti-neutrophil cytoplasmic antibody positive vasculitis
    France Germany Italy Poland Spain

  • Testing a Drug Combination for Personalized Sepsis Treatment in Children and Adults with Severe Blood Infection

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Fludrocortisone Acetate
    • Heparin
    • Human Plasma Protein
    France

  • Study of ALE.

    Recruiting

    2 1 1
    Investigated Drugs:
    • ALE.P03
    France Italy The Netherlands Spain

  • A Study of Atezolizumab and Bevacizumab Before and After Surgery in Patients with Liver Cancer at High Risk of Coming Back

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Hepatocellular carcinoma
    Investigated Drugs:
    • Atezolizumab
    • Bevacizumab
    Spain

  • A Study Testing Erector Spinae Plane Block with Ropivacaine versus Placebo for Pain Relief in Adults with Acute Kidney Stone Pain in the Emergency Department

    Recruiting

    3 1 1
    Investigated Drugs:
    • Ropivacaine Hydrochloride
    • Sodium Chloride Ph. Eur.
    • Sodium Hydrogen Carbonate Pheur
    The Netherlands
Previous Page
1 … 97 98 99 100 101 … 1,646
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!